| View |
|
DR-XY47534
|
Multivitamins
|
Enervon
|
Formulation: Each sugar-coated tablet contains:
Ascorbic Acid-500mg Thiamine Mononitrate (Vit. B3)-50mg Nicotinamide (Vit. B3)-50 mg Riboflavin (Vit. B2)-20 mg
Calcium Pantothenate (Vit. B5)-20mg Pyridoxine Hydrochloride (Vit. B6)-5mg Cyanocobalamin (Vit. B12)-5mcg
|
Sugar-Coated Tablet
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
17 November 2021
|
17 November 2026
|
| View |
|
DRHR-2096
|
Carbocisteine
|
Solmux
|
500 mg
|
Capsule
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
18 November 2021
|
18 November 2026
|
| View |
|
DRHR-2097
|
Carbocisteine
|
Solmux
|
500 mg
|
Capsule
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
Initial [HR]
|
18 November 2021
|
18 November 2026
|
| View |
|
DRP-10775
|
Multivitamins + Iron + Buclizine
|
Neurolem Plus
|
Formulation
Each capsule contains: Iron (equivalent to 81.25 mg Ferrous Sulfate)-26 mg Buclizine Hydrochloride-25 mg Nicotinamide Vit. B3)-20 mg
Thiamine Mononitrate (Vit B1)-10 mg Pyridoxine Hydrochloride (Vit B6)-5 mg Riboflavin (Vit B2)-1.8 mg Cyanocobalamin (Vit B12)-5 mcg
|
Capsule
|
-
|
Diamond Laboratories Inc.
|
Philippines
|
-
|
18 November 2021
|
18 November 2026
|
| View |
|
DRP-6452-02
|
Ambroxol Hydrochloride + Levocetirizine Hydrochloride
|
None
|
75 mg/ 5 mg
|
Sustained- Released Tablet
|
-
|
Inventia Healthcare Limited
|
India
|
-
|
17 November 2021
|
09 December 2025
|
| View |
|
DRP-6452-01
|
Ambroxol Hydrochloride + Levocetirizine Hydrochloride
|
None
|
75 mg/ 5 mg
|
Sustained- Released Tablet
|
-
|
Inventia Healthcare Limited
|
India
|
-
|
16 November 2021
|
09 December 2025
|
| View |
|
HRP-446-01
|
2,4-Dichlorobenzyl Alcohol + Amylmetacresol
|
Therasil (Black Currant Flavor)
|
1.2 mg/600 mcg
|
Lozenge
|
Antiseptic
|
Plethico Pharmaceuticals Ltd.
|
India
|
Automatic Renewal
|
09 March 2022
|
09 May 2027
|
| View |
|
HRP-444-01
|
2,4-Dichlorobenzyl Alcohol + Amylmetacresol
|
Therasil (Honey and Lemon Flavor)
|
1.2 mg/600 mcg
|
Lozenge
|
Antiseptic
|
Plethico Pharmaceuticals Limited
|
India
|
Automatic Renewal
|
03 March 2022
|
24 April 2027
|
| View |
|
HRP-445-01
|
2, 4 Dichlorobenzyl Alcohol + Amylmetacresol
|
Therasil (Orange Flavor)
|
1.2 mg/600 mcg
|
Lozenge
|
Antiseptic
|
Plethico Pharmaceuticals Ltd.
|
India
|
Automatic Renewal
|
24 March 2022
|
24 April 2027
|
| View |
|
DRP-10776
|
Loratadine
|
None
|
10 mg
|
Chewable Tablet
|
-
|
PHIL. UNITED PHARMA CORPORATION
|
Philippines
|
-
|
18 November 2021
|
18 November 2026
|
| View |
|
DRP-10778
|
Loratadine
|
Lorine 10 CT
|
10 mg
|
Chewable Tablet
|
-
|
Phil. United Pharma Corp.
|
Philippines
|
-
|
19 November 2021
|
19 November 2026
|
| View |
|
DRP-10777
|
Loratadine
|
Lorago 10 Ct
|
10 mg
|
Chewable Tablet
|
-
|
Phil. United Pharma Corp.
|
Philippines
|
-
|
19 November 2021
|
19 November 2026
|
| View |
|
DRP-10779
|
Aluminum Hydroxide + Magnesium Hydroxide
|
None
|
200 mg/200 mg
|
Chewable Tablet (Peppermint Flavor)
|
-
|
Centurion Laboratories Pvt. Ltd.
|
India
|
-
|
19 November 2021
|
19 November 2026
|
| View |
|
DRP-5457-05
|
Tramadol (as hydrochloride)
|
Meditram
|
50 mg/mL
|
Solution For Injection (IM/IV/SC)
|
Opioid Analgesic
|
Cooper Pharma Limited
|
India
|
Renewal
|
17 April 2024
|
18 August 2029
|
| View |
|
DRP-6419-03
|
Carvedilol
|
Unbranded
|
6.25 mg
|
Tablet
|
Combined Alpha and Beta-Adrenoreceptor Blocker
|
Hizon Laboratories Inc.
|
Philippines
|
Renewal
|
25 July 2024
|
15 July 2029
|
| View |
|
DRP-1630-05
|
Losartan Potassium / Hydrochlorothiazide
|
Unbranded
|
100 mg / 25 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker/Diuretic
|
Hizon Laboratories, Inc.
|
Philippines
|
Renewal
|
19 June 2024
|
24 June 2029
|
| View |
|
DRP-4164-30
|
Cefuroxime (As Axetil)
|
Rhyximex
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Brawn Laboratories Ltd.
|
India
|
Renewal
|
19 April 2022
|
27 December 2027
|
| View |
|
DRP-8900-02
|
Sitagliptin (as phosphate)
|
Gliptadin
|
100 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
|
Sai Mirra Innopharm Pvt. Ltd.
|
India
|
Renewal
|
04 September 2024
|
08 June 2030
|
| View |
|
DRP-8044-02
|
Tobramycin
|
Raytobrax
|
3 mg/mL (0.3% w/v)
|
Sterile Ophthalmic Solution (Eye Drops)
|
Antibacterial (Aminoglycoside)
|
Egyptian International Pharmaceutical Industries Co. (EIPICO)
|
Egypt
|
Automatic Renewal
|
05 October 2022
|
05 December 2028
|
| View |
|
DRP-8985-03
|
Losartan Potassium
|
Gisart 50
|
50 mg
|
Film-Coated Tablet
|
-
|
Zim Laboratories Limited
|
India
|
-
|
04 April 2022
|
21 July 2025
|